Publications:

Articles

  1. Evan Z. Lang, Frits van Rhee, Idiopathic Multicentric Castleman disease. American Journal of Hematology, in progress.

 

  1. Evan Z. Lang, Brenda Sande, Samantha Brodkin, and Frits van Rhee, Idiopathic Multicentric Castleman Disease Treated with Siltuximab for 15 years. Therapeutic Advances in Hematology, Vol. 13: 1-6, 2022.

 

  1. Johanna Bendell, Ahmed Zakari, Evan Z. Lang, David Waterhouse, Douglas Flora, Kathryn Alguire, Michael McCleod, Nancy W. Peacock, Peter G. Ruehlman, Cassie Lane, Chris Earwood, & Kent Shih. Bevacizumab, Pertuzumab, and Sandostatin for Patients with Advanced Neuroendocrine Cancers (NET): A Phase ll Study of the Sarah Cannon Oncology Research Consortium. 2016

 

  1. Eshleman JR, Markowitz SD, Scott P, Lang EZ, Lutterbaugh JD, Goumin Leo, Lee M, Veigl ML, and Sedwick WD. Diverse Hypermutability of Multiple Expressed Sequences of Motifs Present in Cancers with Microsatellite Instability. Oncogene, April 1996.

 

  1. Eshleman, JR, Lang EZ, Bowerfind GK, Parsons R, Vogelstein B, Willson JVK, Veigl M, Sedwick WD, and Markowitz S. Increased Mutation Rate at the hprt Locus Accompanies Microsatellite Instability in Colon Cancer. Oncogene, 10, 33-37, 1995.

 

Abstract

  1. Ian W. Flinn, MD, PhD; Evan Z. Lang, MD; Eric L Raefsky, MD; Ralph V. Boccia, MD; Inés M. Marcias-Pérez, PhD; Howard H. Burris, lll, MD; John D Hainsworth MD. A Phase II Trial for Panobinostat in Refractory Myelodysplastic Syndromes (MDS) Patients, ASCO Presentation 2010

 

  1. Eshleman JR, Lang EZ, Lutterbaugh JD, Bowerfind GK, Parson R, Vogelstein B, Willson JKV, Veigl ML, Markowitz SD and Sedwick WD. Molecular Ananlysis of Spontaneous Mutations in Colon Cancer

 

  1. Exhibiting Microsatellite Instability. Proceedings of the American Association for Cancer Research, 36, 145, March 1995